Ajovy 欧州連合 - 英語 - EMA (European Medicines Agency)

ajovy

teva gmbh - fremanezumab - migraine disorders - calcitonin gene-related peptide (cgrp) antagonists - ajovy is indicated for prophylaxis of migraine in adults who have at least 4 migraine days per month.

AJOVY SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 225 MG1.5ML シンガポール - 英語 - HSA (Health Sciences Authority)

ajovy solution for injection in pre-filled syringe 225 mg1.5ml

teva pharmaceutical investments singapore pte. ltd. - fremanezumab - injection, solution - fremanezumab 225 mg/1.5 ml

AJOVY SOLUTION FOR INJECTION IN PRE-FILLED PEN 225 MG1.5ML シンガポール - 英語 - HSA (Health Sciences Authority)

ajovy solution for injection in pre-filled pen 225 mg1.5ml

teva pharmaceutical investments singapore pte. ltd. - fremanezumab - injection, solution - fremanezumab 225 mg/1.5ml

AJOVY イスラエル - 英語 - Ministry of Health

ajovy

abic marketing ltd, israel - fremanezumab - solution for injection - fremanezumab 225 mg / 1.5 ml - ajovy is indicated for prophylaxis of migraine in adults who have at least 4 migraine days per month.

AJOVY SOLUTION カナダ - 英語 - Health Canada

ajovy solution

teva canada limited - fremanezumab - solution - 225mg - fremanezumab 225mg - calcitonin-gene-related peptide (cgrp) antagonists

AJOVY SOLUTION カナダ - 英語 - Health Canada

ajovy solution

teva canada limited - fremanezumab - solution - 225mg - fremanezumab 225mg - calcitonin-gene-related peptide (cgrp) antagonists

AJOVY INJECTION 南アフリカ - 英語 - South African Health Products Regulatory Authority (SAHPRA)

ajovy injection

teva pharmaceuticals (pty) ltd - injection - see ingredients - each syringe or pen contains fremanezumab 225,0 mg

FREMANEZUMAB TEVA INJECTION 南アフリカ - 英語 - South African Health Products Regulatory Authority (SAHPRA)

fremanezumab teva injection

teva pharmaceuticals (pty) ltd - injection - see ingredients - each syringe or pen contains fremanezumab 225,0 mg

AJOVY fremanezumab 225 mg/1.5 mL solution for injection in a pre-filled syringe オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

ajovy fremanezumab 225 mg/1.5 ml solution for injection in a pre-filled syringe

teva pharma australia pty ltd - fremanezumab, quantity: 225 mg - injection, solution - excipient ingredients: histidine hydrochloride monohydrate; histidine; polysorbate 80; disodium edetate; sucrose; water for injections - ajovy is indicated for the preventive treatment of migraine in adults.

AJOVY fremanezumab 225 mg/1.5 mL solution for injection in an autoinjector オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

ajovy fremanezumab 225 mg/1.5 ml solution for injection in an autoinjector

teva pharma australia pty ltd - fremanezumab, quantity: 225 mg - injection, solution - excipient ingredients: histidine; disodium edetate; histidine hydrochloride monohydrate; polysorbate 80; sucrose; water for injections - ajovy is indicated for the preventive treatment of migraine in adults.